Trulieve Q2 Revenue Declines 10% YoY, What About Adjusted EBITDA?

Trulieve Cannabis Corp. TCNNF TRUL released its results for the quarter ended June 30, 2023, revealing revenue of $282 million, a decrease of 10% compared to $314 million in Q2 2022.

Q2 2023 Financial Highlights

  • Gross profit of $142 million, a decrease of 23% compared to $183 million in Q2 2022.

  • Gross margin of 50% compared to 58% in Q2 2022.

  • Net loss of $404 million, compared to loss of $22 million.

  • Adjusted EBITDA of $79 million, a decrease of 29% compared to $111 million in Q2 2022.

  • Cash at quarter end of $160 million.

"Demand for legal cannabis remains strong and Trulieve sells the highest volume of branded product through branded retail in the U.S.," stated Kim Rivers, Trulieve CEO. "Our focused strategy, scaled operations and leading retail position provide distinct competitive advantages. We are on track to exit this year as a leaner, stronger organization, ready to meet the opportunities ahead."

Benzinga Cannabis Capital Conference

The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.

Photo by Esteban López on Unsplash

Related News

Florida Attorney General Implies Voters Are Not Too Bright, Deceived By 'Monopolistic' Weed Giant To Legalize Cannabis

Here's Where To Buy Legal Weed: Jim Belushi's Farm Teams Up With Shop In SD, New Stores In US And Canada

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksSmall CapMarketsKim Riverspremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.